Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Leukemia Research|February 22, 2017
A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblastsKamila Janusz, Mónica Del Rey, María Abáigar, et al.
Annals of Surgical Oncology|March 8, 2012
Integration of global spectral karyotyping, CGH arrays, and expression arrays reveals important genes in the pathogenesis of glioblastoma multiformePaola E Leone, M Belén González, Carolina Elosua, et al.
European Journal of Haematology|October 8, 2016
Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLLIsabel González-Gascón Y Marín, Ana África Martín, María Hernández-Sanchez, et al.
Journal of Human Genetics|November 28, 2019
Frequency of low-level and high-level mosaicism in sporadic retinoblastoma: genotype-phenotype relationshipsCarlos Rodríguez-Martín, Cristina Robledo, Gema Gómez-Mariano, et al.
Ebiomedicine|March 28, 2024
A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcomaVerónica Rey, Juan Tornín, Juan Jose Alba-Linares, et al.
Diagnostics (Basel, Switzerland)|July 9, 2020
Integrated Genomic Analysis of Chromosomal Alterations and Mutations in B-Cell Acute Lymphoblastic Leukemia Reveals Distinct Genetic Profiles at RelapseMaribel Forero-Castro, Adrián Montaño, Cristina Robledo, et al.
American Journal of Hematology|June 15, 2017
Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS groupFernando Ramos, Cristina Robledo, Arturo Pereira, et al.
Leukemia Research|April 26, 2016
MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletionMaría Hernández-Sánchez, Ana E Rodríguez-Vicente, José-Ángel Hernández, et al.
Plos One|October 15, 2016
Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic SyndromesMaría Abáigar, Cristina Robledo, Rocío Benito, et al.
British Journal of Haematology|November 17, 2015
The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximabMaribel Forero-Castro, Cristina Robledo, Eva Lumbreras, et al.
Pageof 3